• Morin, AMPD2, and Podocyte Energy Metabolism

  2026-09-07

  A 2025 study identifies excessive AMPD activity in the purine nucleotide cycle as a mechanistic link between fructose exposure, podocyte mitochondrial dysfunction, and glomerular injury. Using rat and MPC5 podocyte models, the authors show that Morin suppresses this metabolic disturbance and position AMPD2 as a potential target for further kidney research.

• HA Tag Peptide as a Translational Mechanism Tool

  2026-09-07

  Translational researchers need more than pathway diagrams: they need reproducible ways to capture, release, and verify protein complexes. This article examines how the Influenza Hemagglutinin (HA) Peptide can support mechanistic studies of NEDD4L-mediated PRMT5 regulation while clarifying what the colorectal cancer evidence does—and does not—establish.

• Engineering a Simpler Bitespiramycin Producer

  2026-09-05

  The reference study used an in-frame partial deletion of the sspA 3-O-acyltransferase gene to redirect Streptomyces spiramyceticus WSJ-1 toward production of 400-isovalerylspiramycin I with reduced component complexity. Its main contribution is a targeted biosynthetic-engineering strategy that separates pathway control from downstream susceptibility testing and offers a framework for improving antibiotic product consistency.

• Y-27632 Dihydrochloride in Microfabricated Assays

  2026-09-05

  Y-27632 dihydrochloride is a selective ROCK inhibitor for dissecting how cytoskeletal signaling interacts with engineered cell environments. This guide presents a practical framework for combining pharmacological perturbation with rapid, microscope-enabled microfabrication while separating geometry effects from ROCK-dependent biology.

• CRTC-CREB Sensing of Proteotoxic Stress in Drosophila

  2026-09-04

  The reference study identifies CRTC-CREB as a stress-responsive transcriptional system that links proteasome inhibition to ROS and JNK signaling in Drosophila. Its experiments suggest that enhancing this pathway can improve proteostasis and reduce Huntington’s disease-associated protein aggregation, while also defining important limits for translation to mammalian and oncology models.

• T7 RNA Polymerase for Reliable RNA Workflows

  2026-09-04

  This scenario-driven guide explains how T7 RNA Polymerase, SKU K1083, can standardize upstream RNA production for cell viability, proliferation, and cytotoxicity studies. It covers promoter-specific template design, protocol controls, interpretation of biological effects, and practical vendor-selection criteria.

• Sisomicin Activity Versus Tobramycin and Gentamicin

  2026-09-03

  This 1974 study benchmarked sisomicin against five aminoglycosides using 565 clinical isolates, showing broad in vitro activity against Gram-negative bacilli and selected Gram-positive cocci. Its comparative MIC design also identified cross-resistance between sisomicin, gentamicin, and Tobramycin, while highlighting amikacin as a potentially useful option for resistant isolates.

• Acetylcysteine in Redox-Immune Assays

  2026-09-02

  Learn how Acetylcysteine and N-acetyl-L-cysteine can function as mechanistic redox controls in photothermal and immune-remodeling assays, with practical guidance for separating oxidative injury from heat-driven and immune-mediated effects.

• Biotin-XX Tyramide: Assay Design Guide

  2026-09-02

  Biotin-XX Tyramide Reagent enables sensitive, spatially restricted HRP-based labeling for IHC, ISH, and cell-surface proteomics. This guide explains its membrane-impermeant chemistry, serotonin-related interference, controls, and practical assay decisions.

• Anti-HMGB1 Rabbit Monoclonal Antibody Guide

  2026-09-02

  The Anti-HMGB1 Rabbit Monoclonal Antibody, SKU MA3057, supports reproducible research detection of HMGB1 in human, mouse, and rat samples by Western blot, immunohistochemistry, and flow cytometry. It is intended for controlled laboratory use only and should not be used for diagnosis, medical decision-making, or therapeutic applications.

• Breast Adenomyoepithelioma Organoids: Study Insights

  2026-09-01

  This 2021 study established the first reported patient-derived organoid model from breast adenomyoepithelioma and verified its genetic identity using short tandem repeat analysis. The organoids responded to paclitaxel and doxorubicin, supporting their use for studying this rare tumor and evaluating candidate treatments while highlighting the need for broader validation.

• Acridine Orange hydrochloride: Practical Guide

  2026-08-31

  Acridine Orange hydrochloride provides differential fluorescent labeling of double-helical and single-stranded nucleic acids, supporting cytochemical workflows such as cell cycle analysis, apoptosis detection, and flow cytofluorometric nucleic acid staining. It is intended for fresh, controlled staining workflows rather than long-term solution storage or applications unrelated to nucleic acid detection.

• Protease and Phosphatase Inhibitor Cocktail Guide

  2026-08-31

  This EDTA-free 100X reagent helps limit proteolysis and dephosphorylation during extraction from cells, tissues, yeast, and bacteria. It is appropriate when added EDTA or metal chelation is undesirable, but it should not be treated as a universal inhibitor system or a substitute for assay-specific validation.

• Phosbind Biotin for Drought-Response Phosphoproteomics

  2026-08-30

  Phosbind Biotin provides sequence-independent detection of phosphorylated proteins on PVDF membranes. This guide develops a decision-focused workflow for connecting protein phosphorylation analysis with the PtrbZIP12 drought-response mechanism in poplar.

• DRD2 Variants and Pathogenic G Protein Signaling

  2026-08-29

  A 2024 Biochemical Pharmacology study compared two pathogenic DRD2 variants associated with hyperkinetic movement disorders and identified enhanced constitutive and agonist-induced G protein signaling as a likely driver of their clinical effects. The work shows why receptor abundance, arrestin recruitment, thermal stability, and G protein activity must be assessed together when interpreting disease-associated GPCR mutations.

8711 records 1/581 page Next 12345 下5页 Last page